Resources | Sterling Pharma Solutions

Hazardous chemistry in drug development

The growing demand for hazardous chemistry brings new risks that require both chemistry and engineering expertise As new chemical entities…

view

Continuous vs. batch production

While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…

view

CEO spotlight: Kevin Cook

A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…

view

CDMO mega-trends

Kevin Cook, CEO at Sterling Pharma Solutions talks to European Pharmaceutical Manufacturer, along with three other experts, to discuss the…

view

Controlled and effective hazardous chemistry

There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…

view

The CDMO-sponsor relationship

Kevin Cook, CEO at Sterling Pharma Solutions talks to Contract Pharma about the latest trends when it comes to CMO-sponsor…

view

Opportunity knocks: CDMO trends

The contract manufacturing space has gone from strength to strength in the last ten years and in an increasingly crowded…

view

Safe and effective hazardous chemistry

Complex and targeted therapies are dominating the drug development pipeline and the increasing complexity of the chemical entities involved in…

view

Contract manufacturing trends: part two

Contract manufacturing organisations (CMOs) are operating in an increasingly demanding space. Low volume, complex targeted therapies are dominating drug development…

view

Contract manufacturing trends: part one

Changes to the pharmaceutical industry over the last ten years, such as rising price pressures and increasingly complex drugs, have…

view

CDMO supply chain trends

Over the last decade, the landscape for contract development and manufacturing organisations (CDMOs) in the pharmaceutical industry has changed exponentially.…

view
Sterling's Solid Form experts socially distancing

Solid Form Webinar

Watch our pharmaceutical solid form development webinar. Sterling’s Solid State Chemistry team, based in our new Material Science Centre, discuss…

view

HPAPI webinar

Watch our webinar on highly potent APIs (HPAPIs). Adam Kujath, Sterling’s Senior Director of Technical Operations at Germantown, discusses how…

view
High potency APIs video animation

High Potency APIs are on the rise

High potency APIs (HPAPIs) are on the rise; driven in part, by an increase in complex therapeutics and growing sophistication…

view

An overview of Sterling Pharma Solutions

You have a promising small molecule in the pipeline, but commercialising that molecule will require complex and hazardous chemistry. You…

view

Unlocking the potential of highly potent APIs

View our infographic to explore the growth of highly potent molecules and key considerations to unlock their full potential in…

view

Choosing a PDMO for your programme

Outsourcing shouldn't mean that you have to compromise critical visibility, continuity, and control. Discover key characteristics that define a PDMO,…

view
Biocatalysis: Using enzymes as catalysts

Biocatalysis: Using enzymes as catalysts

Nature’s catalysts are everywhere. From craft brewing to industrial manufacturing, these enzymes have the power to accelerate reactions of all…

view
Sterling Pharma Solutions biocatalysis webinar

Biocatalysis webinar

Watch our webinar on Biocatalysis as Mark Muldowney, Head of Technology and Innovation, and Greg Holgate, KTP Associate, discuss the…

view
Making sense of the pharmaceutical supply chain

The pharmaceutical supply chain

Click to download more information about the pharmaceutical supply chain and the power of partner proximity. Want to learn more…

view
Science: What makes a PDMO?

Science: What makes a PDMO?

Click to download our spotlight on 'science' to discover more about what it is that makes Sterling a partnership development…

view
Passion: What makes a PDMO?

Passion: What makes a PDMO?

Click below to download our spotlight on "Passion: What makes a PDMO?" as we explore the elements that contribute towards…

view
Service: What makes a PDMO?

Service: What makes a PDMO?

What is a PDMO, or partnership development and manufacturing organisation? Click to download our spotlight on 'service' as we delve…

view
What is a PDMO, or partnership development and manufacturing organisation?

What is a PDMO?

Download our PDMO overview to discover "what is a PDMO, or partnership development and manufacturing organisation?". At Sterling, we are…

view
Scientist Snapshot: Head of Technology and Innovation, Mark Muldowney

Scientist Snapshot: Head of Technology and In

Click below to download our Scientist Snapshot on Sterling's Head of Technology and Innovation, Mark Muldowney.

view
Biocatalysis whitepaper: Leveraging nature's catalysts in pharmaceutical development

Biocatalysis whitepaper

Click to download our Biocatalysis whitepaper: 'Leveraging nature's catalysts in pharmaceutical development'. Click here to learn more about our biocatalysis…

view

API discovery to manufacture

At Sterling we provide first-class development services using both our state-of-the-art equipment and our experts’ insight to meet customers’ API…

view

From grams to tonnes

Using our first-class facilities and engineering know-how our experienced team provide contract API manufacturing across the whole drug development lifecycle…

view

Podcast: Episode 1

In this podcast facilitated by our Strategic Marketing Manager, Dr. Charlotte Chapman, we talk to Robert Smith, one of our…

view

Working towards ZeroHarm

We're dedicated to achieving ZeroHarm. We believe that safe operations are fundamental to running a good business. Our business is…

view

Sterling quality: FAQ

Sterling Pharma Solutions is an FDA approved contract manufacturer and holds a current MHRA Good Manufacturing Practice (GMP) license. The…

view

New: Material Sciences Centre

Following a £6million investment in 2017 our team has been working on the build of a new facility at our…

view

Sterling in the US

Sterling’s facility in Cary, North Carolina provides us with a physical presence close to the pharmaceutical and biotech hub, Research…

view

Exploring continuous processing

Over the last decade, pharmaceutical companies have started to explore the potential of continuous processing, specifically flow chemistry, for manufacturing…

view

Outsourcing: controlled substances

The potential for controlled substance active pharmaceutical ingredients (APIs) to meet the needs of many clinical conditions including depression, post-traumatic…

view

Sterling: A journey with Chromeleon CDS

In 2012 Sterling Pharma Solutions, a leading provider of small molecule API development and contract manufacturing services to the global…

view